Cinemark's Q3 Net Income Plunges 73% Amid Revenue Dip

TL;DR

**Cinemark's Q3 results are a red flag, showing a massive profit drop and cash burn; time to be cautious on this stock.**

AI Summary

Cinemark Holdings, Inc. reported a significant decline in net income for the three months ended September 30, 2025, falling to $50.5 million from $188.9 million in the prior year, a 73.2% decrease. Total revenue also decreased by 7.0% to $857.5 million from $921.8 million, driven by a drop in admissions revenue to $429.7 million from $460.4 million and concession revenue to $336.7 million from $367.3 million. For the nine months ended September 30, 2025, net income decreased to $106.6 million from $260.8 million in 2024, a 59.1% reduction, despite a slight increase in total revenue to $2,338.7 million from $2,235.2 million. A key business change was the reclassification of warrants to a liability, resulting in a $156.5 million reduction in additional paid-in-capital and a $54.5 million loss on warrants for the nine-month period. The company also saw a substantial increase in treasury stock, from $103.2 million at December 31, 2024, to $464.1 million at September 30, 2025, reflecting significant share repurchases. Cash and cash equivalents decreased sharply from $1,057.3 million at December 31, 2024, to $461.3 million at September 30, 2025. Risks include a $54.5 million loss on warrants and a $9.4 million net loss on investment in NCMI for the nine months ended September 30, 2025, compared to a $12.8 million gain in the prior year.

Why It Matters

This significant drop in net income and revenue for Cinemark Holdings, Inc. signals potential headwinds for the theatrical exhibition industry, impacting investor confidence and potentially leading to a re-evaluation of the company's valuation. For employees, sustained revenue declines could lead to cost-cutting measures, while customers might see changes in pricing or offerings as Cinemark adapts. In a competitive context, streaming services continue to challenge traditional cinema, and this filing suggests Cinemark is struggling to maintain its previous performance, potentially affecting its market share against rivals like AMC Entertainment. The substantial decrease in cash and cash equivalents also raises concerns about liquidity and future investment capacity.

Risk Assessment

Risk Level: high — The risk level is high due to a 73.2% decrease in net income for the three months ended September 30, 2025, to $50.5 million from $188.9 million, and a 59.1% decrease for the nine months to $106.6 million from $260.8 million. Additionally, cash and cash equivalents plummeted by $596.0 million, from $1,057.3 million at December 31, 2024, to $461.3 million at September 30, 2025, indicating significant cash outflow.

Analyst Insight

Investors should consider reducing exposure to Cinemark Holdings, Inc. given the sharp decline in net income and substantial cash burn. Monitor upcoming film slate announcements and attendance trends closely, as a weak content pipeline could further exacerbate revenue pressures.

Financial Highlights

revenue

$857.5M

net Income

$50.5M

eps

$0.40

cash Position

$461.3M

revenue Growth

-7.0%

Revenue Breakdown

Key Numbers

• $50.5M — Net Income (Q3 2025) (73.2% decrease from $188.9M in Q3 2024)
• $857.5M — Total Revenue (Q3 2025) (7.0% decrease from $921.8M in Q3 2024)
• $106.6M — Net Income (YTD Q3 2025) (59.1% decrease from $260.8M in YTD Q3 2024)
• $2,338.7M — Total Revenue (YTD Q3 2025) (4.6% increase from $2,235.2M in YTD Q3 2024)
• $461.3M — Cash and Cash Equivalents (Decreased from $1,057.3M at Dec 31, 2024)
• $156.5M — Reclassification of Warrants (Reduced additional paid-in-capital)
• $54.5M — Loss on Warrants (Incurred for the nine months ended September 30, 2025)
• $464.1M — Treasury Stock (Increased from $103.2M at Dec 31, 2024, due to repurchases)
• $0.40 — Diluted EPS (Q3 2025) (Decreased from $1.19 in Q3 2024)
• $0.77 — Diluted EPS (YTD Q3 2025) (Decreased from $1.73 in YTD Q3 2024)

Key Players & Entities

• Cinemark Holdings, Inc. (company) — registrant and parent company
• Cinemark USA, Inc. (company) — subsidiary and voluntary filer
• New York Stock Exchange (regulator) — exchange where CNK is traded
• NCMI (company) — investment affiliate
• $50.5 million (dollar_amount) — net income for three months ended September 30, 2025
• $188.9 million (dollar_amount) — net income for three months ended September 30, 2024
• $857.5 million (dollar_amount) — total revenue for three months ended September 30, 2025
• $921.8 million (dollar_amount) — total revenue for three months ended September 30, 2024
• $1,057.3 million (dollar_amount) — cash and cash equivalents at December 31, 2024
• $461.3 million (dollar_amount) — cash and cash equivalents at September 30, 2025

FAQ

Risk Factors

• Loss on Warrants [high — financial]: The company incurred a $54.5 million loss on warrants for the nine months ended September 30, 2025, due to a reclassification of warrants to a liability. This reclassification also reduced additional paid-in-capital by $156.5 million.
• Investment in NCMI [medium — financial]: Cinemark experienced a net loss of $9.4 million on its investment in NCMI for the nine months ended September 30, 2025, a significant swing from a $12.8 million gain in the prior year's comparable period.
• Decreased Cash Position [high — financial]: Cash and cash equivalents saw a substantial decrease, falling from $1,057.3 million at December 31, 2024, to $461.3 million at September 30, 2025. This represents a reduction of over 56%.
• Share Repurchases [medium — financial]: The company significantly increased its treasury stock holdings to $464.1 million from $103.2 million at the end of 2024, indicating substantial share repurchases which have impacted cash reserves.
• Declining Revenue and Net Income [high — market]: Total revenue for Q3 2025 decreased by 7.0% to $857.5 million, and net income plummeted by 73.2% to $50.5 million compared to Q3 2024. This trend is also evident year-to-date.
• Reduced Admissions and Concession Revenue [medium — market]: Admissions revenue fell to $429.7 million and concession revenue to $336.7 million in Q3 2025, reflecting lower customer traffic or spending, contributing to the overall revenue decline.

Industry Context

The cinema exhibition industry continues to face challenges in audience recovery and evolving consumer entertainment habits. While some recovery has occurred, the significant drop in Cinemark's Q3 net income suggests ongoing pressures from competition, content availability, and potentially shifting consumer preferences towards home entertainment or other leisure activities.

Regulatory Implications

The reclassification of warrants to a liability and the subsequent loss recognized are accounting treatments that require adherence to specific GAAP guidelines. Any future changes in accounting standards related to financial instruments or equity could impact reporting.

What Investors Should Do

1. Monitor cash flow and liquidity
2. Analyze the impact of share repurchases
3. Evaluate the warrant reclassification impact
4. Assess revenue drivers

Key Dates

• 2025-09-30: Quarterly and Year-to-Date Financial Reporting — Revealed a significant decline in net income and revenue for Q3 2025, alongside a substantial decrease in cash and a large increase in treasury stock.
• 2024-12-31: End of Fiscal Year 2024 — Represents the prior period's financial position, showing higher cash reserves ($1,057.3M) and lower treasury stock ($103.2M) compared to Q3 2025.

Glossary

Additional Paid-In Capital

The amount of money a company receives from selling stock above its par value. (A significant reduction of $156.5 million in this account was noted due to the reclassification of warrants.)

Treasury Stock

Stock that a company has repurchased from the open market. (Increased substantially to $464.1 million, indicating significant share buyback activity.)

Warrants

Financial instruments that give the holder the right, but not the obligation, to purchase a company's stock at a specific price before a certain expiration date. (A reclassification of these to a liability resulted in a $54.5 million loss and impacted equity.)

Diluted EPS

Earnings per share calculated after accounting for all dilutive securities, such as stock options and warrants. (Decreased significantly to $0.40 for Q3 2025 from $1.19 in Q3 2024, reflecting lower profitability on a per-share basis.)

Year-Over-Year Comparison

Compared to the prior year, Cinemark Holdings, Inc. reported a significant downturn in profitability, with net income for Q3 2025 falling 73.2% to $50.5 million and year-to-date net income down 59.1% to $106.6 million. Total revenue also saw a 7.0% decrease in Q3. Key balance sheet changes include a drastic reduction in cash and cash equivalents and a substantial increase in treasury stock due to share repurchases. A notable event was the reclassification of warrants, leading to a $54.5 million loss and a reduction in equity.

Key Financial Figures

• $0.001 — ("Holdings") Common stock, par value $0.001 per share CNK New York Stock Exchan
• $0.01 — , 1,500 shares of Class A common stock, $0.01 par value per share, and 182,648 shares

Filing Documents

• cnk-20250930.htm (10-Q) — 7198KB
• cnk-ex31_1.htm (EX-31.1) — 17KB
• cnk-ex31_2.htm (EX-31.2) — 17KB
• cnk-ex31_3.htm (EX-31.3) — 17KB
• cnk-ex31_4.htm (EX-31.4) — 17KB
• cnk-ex32_1.htm (EX-32.1) — 10KB
• cnk-ex32_2.htm (EX-32.2) — 10KB
• cnk-ex32_3.htm (EX-32.3) — 9KB
• cnk-ex32_4.htm (EX-32.4) — 10KB
• 0001193125-25-265664.txt ( ) — 22411KB
• cnk-20250930.xsd (EX-101.SCH) — 2437KB
• cnk-20250930_htm.xml (XML) — 4660KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1. Cinemark Holdings, Inc. and Subsidiaries Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 3 Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 2024 4 Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2025 and 2024 5 Condensed Consolidated Statements of Equity for the three and nine months ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 8 Cinemark USA, Inc. and Subsidiaries Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 9 Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 2024 10 Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2025 and 2024 11 Condensed Consolidated Statements of Equity for the three and nine months ended September 30, 2025 and 2024 12 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 14 Cinemark Holdings, Inc. and Cinemark USA, Inc. Notes to Condensed Consolidated Financial Statements 15 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 38 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 54 Item 4.

Controls and Procedures

Controls and Procedures 54

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 55 Item 1A.

Risk Factors

Risk Factors 55 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 55 Item 5. Other Information 56 Item 6. Exhibits 62

SIGNATURES

SIGNATURES 63 1 Cautionary Statement Regarding Forward-Looking Statements Certain matters within this Quarterly Report on Form 10-Q include "forward–looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. The "forward-looking statements" include our current expectations, assumptions, estimates and projections about the respective business and industry of Holdings and CUSA. They include statements relating to: future revenue, expenses and profitability; currency exchange rate and inflationary impacts; general economic conditions in the United States and internationally; the future development and expected growth of our business; projected capital expenditures; access to capital resources; attendance at movies generally or in any of the markets in which we operate; the number and diversity of popular movies released, the length of exclusive theatrical release windows and our ability to successfully license and exhibit popular films; national and international growth in our industry; competition from other exhibitors, alternative forms of entertainment and content delivery via streaming and other formats; changes in legislation, government regulations or policies that affect our operations; determinations in lawsuits in which we are a party; and extraordinary events beyond our control, such as conflicts, wars, natural disasters, public health crises, labor strikes, or terrorist acts. You can identify forward-looking statements by the use of words such as "may," "should," "could," "estimates," "predicts," "potential," "continue," "anticipates," "believes," "plans," "expects," "future" and "intends" and similar expressions. These statements are neither historical facts nor guarantees of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projectio

- FINANC IAL INFORMATION

PART I - FINANC IAL INFORMATION

Financ ial Statements

Item 1. Financ ial Statements CINEMARK HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDA TED BALANCE SHEETS (in millions, except share and per share data, unaudited) September 30, December 31, 2025 2024 Assets Current assets Cash and cash equivalents $ 461.3 $ 1,057.3 Inventories 30.0 31.0 Accounts receivable 82.0 104.6 Current income tax receivable 60.0 56.7 Prepaid expenses and other 47.6 48.7 Total current assets 680.9 1,298.3 Theater properties and equipment, net 1,126.2 1,145.1 Operating lease right-of-use assets, net 915.5 930.4 Other long-term assets Goodwill 1,246.5 1,239.6 Intangible assets, net 300.4 300.5 Investment in NCMI 19.7 29.0 Investments in affiliates 23.3 26.2 Long-term deferred tax asset 97.5 69.5 Deferred charges and other assets 25.6 28.4 Total other long-term assets 1,713.0 1,693.2 Total assets $ 4,435.6 $ 5,067.0 Liabilities and equity Current liabilities Current portion of long-term debt $ 6.4 $ 464.3 Current portion of operating lease obligations 215.5 212.1 Current portion of finance lease obligations 16.2 15.4 Current income tax payable 6.1 5.6 Liability for warrants 132.6 — Accounts payable and accrued expenses 521.3 584.3 Total current liabilities 898.1 1,281.7 Long-term liabilities Long-term debt, less current portion 1,869.6 1,870.4 Operating lease obligations, less current portion 758.0 784.0 Finance lease obligations, less current portion 97.9 109.9 Long-term deferred tax liability 4.7 3.2 Long-term liability for uncertain tax positions 55.8 51.5 NCM screen advertising advances 310.1 318.5 Other long-term liabilities 49.0 44.4 Total long-term liabilities 3,145.1 3,181.9 Equity Cinemark Holdings, Inc.'s stockholders' equity: Common stock, $ 0.001 par value: 300,000,000 shares authorized, 147,717,029 share

View Full Filing

View this 10-Q filing on SEC EDGAR